# A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients

> **NCT00827112** · PHASE2 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 129 (actual)

## Conditions studied

- Human Immunodeficiency Virus-1

## Interventions

- **DRUG:** maraviroc
- **DRUG:** maraviroc

## Key facts

- **NCT ID:** NCT00827112
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2010-07
- **Final completion:** 2011-07
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2012-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00827112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00827112, "A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00827112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*